Hacker News Reader

You're talking about this one drug in question, Daraprim. He actively funded the development of several new drugs you've never heard of, and sending Shkreli to prison was literally a crime against humanity. I don't think you know anything about Shkreli you haven't read in neatly packaged hit pieces.

View on HN

He pulled the same trick with Thiona, Chenodal, Vecamyl and probably more -- it was on the record as his own company Turing's strategy after all.

As noted, this was all legal and I agree that he was railroaded to jail for essentially completely unrelated wrongdoings, but there's no universe where he's not a scumbag.

This is a very odd characterization! Looking at Turing's 2014 10-K, I see this as a listed strategy:

Focus on developing products to treat rare diseases characterized by severe unmet medical needs.

I also see several preclinical programs and product candidates. You must have missed those. Odd case, very strange.

Reply on news.ycombinator.com